The on-chip NAFLD model mimicked the characteristics of NAFLD <i>in vivo</i>, including intracellular lipid accumulation and impaired hepatocyte functions in albumin synthesis, levels of urea, CYP1A2, and CYP3A4. The gene discussed is CYP3A4; the disease is metabolic dysfunction-associated steatotic liver disease.